Top stories

View all news

24 June 2022

Gavi board responds to an uncertain world: fragile and conflict settings, future pandemics and the ongoing fight against COVID-19

Gavi’s Board Meeting emphasizes public health impact with renewed push for routine immunization and reaching zero-dose children.

21 June 2022

Gavi launches new partnership to reach “zero-dose” children across marginalised communities

At least 12.4 million children worldwide are categorised as “zero-dose”,  living in missed communities that cannot access many essential services, including health care.

19 May 2022

COVAX calls for urgent action to close vaccine equity gap

COVAX has access to enough COVID-19 vaccines to help protect 70% of the population in 91 lower-income countries

COVAX deliveries of COVID-19 vaccines

>1.5 bn COVAX vaccines shipped
OWP
144 participants

As of 20 May 2022

COVAX Facility

Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. This involves coordinating the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.

Learn more

 

 

#VaccinesWork

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

COVID-19 vaccines

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Top VaccinesWork stories

View all stories

24 June 2022

World’s worst air pollution slashes 7 years off life expectancy in Bangladesh

Air pollution in Bangladesh is the worst in the world, a new study shows, reducing the average Bangladeshi’s life expectancy by 6.7 years. Another study estimates there were 24,000 premature deaths as a result of air pollution in the country’s…

24 June 2022

Genomic data sheds light on monkeypox origins

The current monkeypox outbreak arose from a single human case, amplified through one or more super-spreader events, according to new research.

24 June 2022

How mapping snakebite hotspots could help tackle this poisonous problem

Climate change could increase the incidence of snakebite, but better data on where it occurs and greater access to antivenin could help millions, now.

Our impact

Syringe >888 million children immunised
First aid locator >15 million future deaths prevented
Transitioned 16 countries transitioned from Gavi support
Billions >230 US$ billion in economic benefits for countries (2000–2020)
Children 78% of the world's children reached by routine immunisation

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Subscribe to our newsletter